Bandingkan Harga & Kinerja Adiwarna Anugerah Abadi Tbk. (NAIK) vs Tempo Scan Pacific Tbk. (TSPC)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Adiwarna Anugerah Abadi Tbk. dan Tempo Scan Pacific Tbk.: Adiwarna Anugerah Abadi Tbk. diperdagangkan di Rp90 (kapitalisasi pasar 292,99 M, volume 24 jam 3,12 jt), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.580 (kapitalisasi pasar 11,68 T, volume 24 jam 429,7 rb). Perbedaan utamanya: Tempo Scan Pacific Tbk. jauh lebih besar — sekitar 39,9× kapitalisasi pasar Adiwarna Anugerah Abadi Tbk., dan Adiwarna Anugerah Abadi Tbk. lebih aktif diperdagangkan (3,12 jt vs 429,7 rb). Mana yang lebih baik tergantung tujuan investasimu.
| NAIK | TSPC | |
|---|---|---|
Kapitalisasi Pasar | 292,99 M | 11,68 T |
Volume | 3,12 jt | 429,7 rb |
Lot | 31,24 rb | 4,3 rb |
Perputaran | 277,73 jt | 1,11 M |
Harga Rata-rata | 88,91 | 2.591,65 |
Nilai Transaksi | 277,73 jt | 1,11 M |
Harga Ekuilibrium Indikatif | 90 | 2.580 |
Volume Ekuilibrium Indikatif | 209 | 100 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Adiwarna Anugerah Abadi Tbk.
PT Adiwarna Anugerah Abadi Tbk was established based on Deed of notary Rony Saputra Sudarmo, SH., No.4 dated 8 May 2007. The Company started its commercial operations in 2007. The Company parent entity is PT Adiwarna Anugerah Investama. Mr. Johannes and Mrs. Ernawati is the final controller of the Company.
Selengkapnya di halaman NAIK →Tentang Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Selengkapnya di halaman TSPC →
